Melatonin high-affinity binding to alpha-1-acid glycoprotein in human serum

被引:36
作者
Morin, D
Simon, N
DepresBrummer, P
Levi, F
Tillement, JP
Urien, S
机构
[1] FAC MED,PHARMACOL LAB,F-94010 CRETEIL,FRANCE
[2] CNRS,PARIS,FRANCE
[3] UNIV PARIS 11,HOP PAUL BROUSSE,VILLEJUIF,FRANCE
[4] ICIG,LAB RYTHMES BIOL & CHRONOTHERAPEUT,VILLEJUIF,FRANCE
[5] INSERM,PARIS,FRANCE
关键词
melatonin; serum binding; protein binding; alpha(1)-acid glycoprotein;
D O I
10.1159/000139495
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The binding of H-3-melatonin to human serum proteins was investigated by equilibrium dialysis at 37 degrees C and pH 7.4. The binding to serum was moderate (53%) for physiological melatonin concentrations below 1 nmol/l. alpha(1)-Acid glycoprotein and albumin bound melatonin with high 27 +/- 3 and low 1.5 +/- 0.1 (mmol/l)(-1) affinity, respectively. Melatonin binding to other serum proteins, gamma-globulins and lipoproteins was not significant. The serum binding was characterized by a saturable and a nonsaturable component. The saturable component resulted from the high-affinity binding to alpha(1)-acid glycoprotein and the nonsaturable component resulted from the low-affinity binding to albumin. The number of binding sites was 0.36/molecule of alpha(1)-acid glycoprotein, when either pure alpha(1)-acid glycoprotein or serum were studied, indicating that only a fraction of alpha(1)-acid glycoprotein bound melatonin. The observed binding parameters did not enable simulation of the observed serum binding, and melatonin binding to an alpha(1)-acid glycoprotein-albumin mixture was higher than that expected from the binding to each isolated protein. The high-affinity melatonin binding to alpha(1)-acid glycoprotein might result from a potentiation of the binding interaction by albumin and the amount of melatonin bound in plasma might vary according to the al-acid glycoprotein concentration.
引用
收藏
页码:271 / 275
页数:5
相关论文
共 11 条
[1]  
BRORS O, 1980, BR J CLIN PHARM, V20, P85
[2]   BINDING OF MELATONIN TO HUMAN AND RAT PLASMA-PROTEINS [J].
CARDINALI, DP ;
WURTMAN, RJ ;
LYNCH, HJ .
ENDOCRINOLOGY, 1972, 91 (05) :1213-+
[3]   MODIFICATION OF PROPRANOLOL BINDING TO ALPHA-1-ACID GLYCOPROTEIN BY SERUM-ALBUMIN [J].
CHAUVELOTMOACHON, L ;
MARQUIS, O ;
GIROUD, JP .
BIOCHEMICAL PHARMACOLOGY, 1985, 34 (09) :1591-1594
[4]   EVIDENCE FOR DIFFERENCES IN THE BINDING OF DRUGS TO THE 2 MAIN GENETIC-VARIANTS OF HUMAN ALPHA(1)-ACID GLYCOPROTEIN [J].
HERVE, F ;
GOMAS, E ;
DUCHE, JC ;
TILLEMENT, JP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (03) :241-249
[5]   PHARMACOKINETICS OF MELATONIN IN MAN AFTER INTRAVENOUS-INFUSION AND BOLUS INJECTION [J].
MALLO, C ;
ZAIDAN, R ;
GALY, G ;
VERMEULEN, E ;
BRUN, J ;
CHAZOT, G ;
CLAUSTRAT, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (03) :297-301
[6]   SEX-RELATED DIFFERENCES IN THE PLASMA-PROTEIN BINDING OF LIGNOCAINE AND DIAZEPAM [J].
ROUTLEDGE, PA ;
STARGEL, WW ;
KITCHELL, BB ;
BARCHOWSKY, A ;
SHAND, DG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (03) :245-250
[7]   THE PLASMA-PROTEIN BINDING OF BASIC DRUGS [J].
ROUTLEDGE, PA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (05) :499-506
[8]   COMPARISON OF THE EFFECTS OF ACUTE FLUVOXAMINE AND DESIPRAMINE ADMINISTRATION ON MELATONIN AND CORTISOL PRODUCTION IN HUMANS [J].
SKENE, DJ ;
BOJKOWSKI, CJ ;
ARENDT, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (02) :181-186
[9]  
Tillement J.P., 1984, ADV DRUG RES, V13, P59
[10]   BINDING OF INDAPAMIDE TO SERUM-PROTEINS AND ERYTHROCYTES [J].
URIEN, S ;
RIANT, P ;
RENOUARD, A ;
COULOMB, B ;
ROCHER, I ;
TILLEMENT, JP .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (15) :2963-2966